학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 14건 | 목록 1~20
Academic Journal
Czako B; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Sun Y; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; McAfoos T; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Cross JB; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Leonard PG; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Burke JP; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Carroll CL; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Feng N; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Harris AL; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Jiang Y; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Kang Z; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Kovacs JJ; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Mandal P; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Meyers BA; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Mseeh F; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Parker CA; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Yu SS; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Williams CC; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Wu Q; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Di Francesco ME; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Draetta G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Heffernan T; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Marszalek JR; TRACTION (Translational Research to AdvanCe Therapeutics and Innovation in Oncology) University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.; Kohl NE; Navire Inc., 421 Kipling Street, Palo Alto, California 94301, United States.; Jones P; IACS (Institute for Applied Cancer Science), University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, Texas 77054, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Soth MJ; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Le K; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Di Francesco ME; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Hamilton MM; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Liu G; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Burke JP; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Carroll CL; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Kovacs JJ; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Bardenhagen JP; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Bristow CA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Cardozo M; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Czako B; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; de Stanchina E; Antitumor Assessment Core Facility-Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Feng N; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Garvey JR; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Gay JP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Do MKG; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Greer J; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Han M; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Harris A; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Herrera Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Huang S; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Giuliani V; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Jiang Y; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Johnson SB; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Johnson TA; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Kang Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Leonard PG; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Liu Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; McAfoos T; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Miller M; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Morlacchi P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Mullinax RA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Palmer WS; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Pang J; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Rogers N; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Rudin CM; Drunkenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York New York 10065, United States.; Shepard HE; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Spencer ND; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Theroff J; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Wu Q; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Xu A; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Yau JA; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Draetta G; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Toniatti C; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Heffernan TP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Jones P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Sun Y; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ysun8@mdanderson.org.; Meyers BA; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Czako B; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Leonard P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mseeh F; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Harris AL; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wu Q; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Johnson S; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Parker CA; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cross JB; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Di Francesco ME; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bivona BJ; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bristow CA; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Burke JP; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Carrillo CC; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Carroll CL; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Chang Q; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Feng N; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gao G; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Gera S; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Giuliani V; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Huang JK; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Jiang Y; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kang Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kovacs JJ; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Liu CY; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lopez AM; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ma X; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mandal PK; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; McAfoos T; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Miller MA; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Mullinax RA; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Peoples M; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ramamoorthy V; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Seth S; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Spencer ND; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Suzuki E; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Williams CC; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Yu SS; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.; Zuniga AM; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Draetta GF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Marszalek JR; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Heffernan TP; TRACTION - Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kohl NE; Navire Pharma, San Francisco, California.; Jones P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Molina JR; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sun Y; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Protopopova M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gera S; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bandi M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bristow C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McAfoos T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morlacchi P; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Agilent Technologies Inc., Lexington, MA, USA.; Ackroyd J; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA.; Agip AA; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK.; Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Asara J; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Bardenhagen J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carrillo CC; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carroll C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chang E; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ciurea S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cross JB; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Czako B; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deem A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; de Groot JF; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dong JW; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao G; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do MG; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Greer J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Giuliani V; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han L; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Henry VK; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hirst J; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK.; Huang S; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang Y; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kang Z; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Khor T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Konoplev S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin YH; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA.; Liu G; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lodi A; Department of Nutritional Sciences, University of Texas at Austin, Austin, TX, USA.; Lofton T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ma H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mahendra M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Matre P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mullinax R; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peoples M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Petrocchi A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez-Canale J; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Serreli R; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK.; Shi T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Smith M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tabe Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Next Generation Hematology Laboratory Medicine, Department of Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.; Theroff J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tiziani S; Department of Nutritional Sciences, University of Texas at Austin, Austin, TX, USA.; Xu Q; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang Q; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Muller F; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA.; DePinho RA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Toniatti C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Draetta GF; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Heffernan TP; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jones P; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Di Francesco ME; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marszalek JR; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Kato H; Department of Natural Products, Graduate School of Pharmaceutical Sciences, Kumamoto University, Oe-honmachi 5-1, Kumamoto 862-0973, Japan.; Kai A; Department of Natural Products, Graduate School of Pharmaceutical Sciences, Kumamoto University, Oe-honmachi 5-1, Kumamoto 862-0973, Japan.; Kawabata T; Department of Natural Products, Graduate School of Pharmaceutical Sciences, Kumamoto University, Oe-honmachi 5-1, Kumamoto 862-0973, Japan.; Sunderhaus JD; Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, CO 80523, United States.; McAfoos TJ; Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, CO 80523, United States.; Finefield JM; Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, CO 80523, United States.; Sugimoto Y; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Oe-honmachi 5-1, Kumamoto 862-0973, Japan.; Williams RM; Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, CO 80523, United States; University of Colorado Cancer Center, Aurora, CO 80045, United States.; Tsukamoto S; Department of Natural Products, Graduate School of Pharmaceutical Sciences, Kumamoto University, Oe-honmachi 5-1, Kumamoto 862-0973, Japan. Electronic address: sachiko@kumamoto-u.ac.jp.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: PubMed not MEDLINE
Academic Journal
Synfacts; Mar2013, Vol. 9 Issue 3, p242-242, 1p
검색 결과 제한하기
제한된 항목
[검색어] McAfoos, T.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어